Klaus Kopka

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 46

Top Venues

Pharmaceuticals (Basel, Switzerland)

EJNMMI radiopharmacy and chemistry

Dalton transactions (Cambridge, England : 2003)

Cancers

Helmholtz-Zentrum Dresden-Rossendorf

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Helmholtz-Zentrum Dresden-Rossendorf Nov 01 2019

Germany

Director :: Institute of Radiopharmaceutical Cancer Research

Publications

Matthias Miederer, Martina Benešová-Schäfer, Constantin Mamat, David Kästner, Marc Pretze, Enrico Michler, Claudia Brogsitter, Jörg Kotzerke, Klaus Kopka, David A Scheinberg, Michael R McDevitt
Alpha-Emitting Radionuclides: Current Status and Future Perspectives. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Peter Jh Scott, Ivan Penuelas, Ana Rey, Silvio Aime, Pillai M R Ambikalmajan, Ines Farinha Antunes, Frederik Cleeren, Zhaofei Liu, Beverley Ellis, Maryke Kahts, Fany Pricile Ekoume, Ivis F Chaple, Emerson Bernardes, Martin Behe, Ya-Yao Huang, Renata Mikolajczak, Shozo Furumoto, Amal Elrefaei, Klaus Kopka
Highlight selection of radiochemistry and radiopharmacy developments by editorial board. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Matthias Miederer, Martina Benešová-Schäfer, Constantin Mamat, David Kästner, Marc Pretze, Enrico Michler, Claudia Brogsitter, Jörg Kotzerke, Klaus Kopka, David A Scheinberg, Michael R McDevitt
Alpha-Emitting Radionuclides: Current Status and Future Perspectives. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Thu Hang Lai, Barbara Wenzel, Sladjana Dukić-Stefanović, Rodrigo Teodoro, Lucie Arnaud, Aurélie Maisonial-Besset, Valérie Weber, Rareş-Petru Moldovan, Sebastian Meister, Jens Pietzsch, Klaus Kopka, Tareq A Juratli, Winnie Deuther-Conrad, Magali Toussaint
Correction to: Radiosynthesis and biological evaluation of [ 18 F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma. European journal of nuclear medicine and molecular imaging (2024)
Matthias Miederer, Martina Benešová-Schäfer, Constantin Mamat, David Kästner, Marc Pretze, Enrico Michler, Claudia Brogsitter, Jörg Kotzerke, Klaus Kopka, David A Scheinberg, Michael R McDevitt
Alpha-Emitting Radionuclides: Current Status and Future Perspectives. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Marlene Schlesinger, Christian Jentschel, Hans-Jürgen Pietzsch, Klaus Kopka, Constantin Mamat
Copper-free click bioconjugation of technetium-99m complexes using strained cyclononyne derivatives. Dalton transactions (Cambridge, England : 2003) 52 (10) (2023)
Torsten Kniess, Jörg Zessin, Peter Mäding, Manuela Kuchar, Oliver C Neels, Klaus Kopka
Synthesis of [ 18 F]FMISO, a hypoxia-specific imaging probe for PET, an overview from a radiochemist's perspective. EJNMMI radiopharmacy and chemistry 8 (1) (2023)
Carsten Sven Kramer, Thines Kanagasundaram, Jessica Matthias, Klaus Kopka
Efforts toward PET-Activatable Red-Shifted Silicon Rhodamines and Silicon Pyronine Dyes. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Thu Hang Lai, Barbara Wenzel, Sladjana Dukić-Stefanović, Rodrigo Teodoro, Lucie Arnaud, Aurélie Maisonial-Besset, Valérie Weber, Rareş-Petru Moldovan, Sebastian Meister, Jens Pietzsch, Klaus Kopka, Tareq A Juratli, Winnie Deuther-Conrad, Magali Toussaint
Radiosynthesis and biological evaluation of [ 18 F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma. European journal of nuclear medicine and molecular imaging (2023)
Carsten Sven Kramer, Thines Kanagasundaram, Jessica Matthias, Klaus Kopka
Efforts toward PET-Activatable Red-Shifted Silicon Rhodamines and Silicon Pyronine Dyes. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Marlene Schlesinger, Christian Jentschel, Hans-Jürgen Pietzsch, Klaus Kopka, Constantin Mamat
Copper-free click bioconjugation of technetium-99m complexes using strained cyclononyne derivatives. Dalton transactions (Cambridge, England : 2003) 52 (10) (2023)
Fabian Krutzek, Cornelius K Donat, Martin Ullrich, Kristof Zarschler, Marie-Charlotte Ludik, Anja Feldmann, Liliana R Loureiro, Klaus Kopka, Sven Stadlbauer
Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1. Cancers 15 (9) (2023)
Barbara Wenzel, Maximilian Schmid, Rodrigo Teodoro, Rareş-Petru Moldovan, Thu Hang Lai, Franziska Mitrach, Klaus Kopka, Björn Fischer, Michaela Schulz-Siegmund, Peter Brust, Michael C Hacker
Radiofluorination of an Anionic, Azide-Functionalized Teroligomer by Copper-Catalyzed Azide-Alkyne Cycloaddition. Nanomaterials (Basel, Switzerland) 13 (14) (2023)
Fabian Krutzek, Cornelius K Donat, Martin Ullrich, Kristof Zarschler, Marie-Charlotte Ludik, Anja Feldmann, Liliana R Loureiro, Klaus Kopka, Sven Stadlbauer
Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1. Cancers 15 (9) (2023)
Austin Craig, Jürgen Kogler, Markus Laube, Martin Ullrich, Cornelius K Donat, Robert Wodtke, Klaus Kopka, Sven Stadlbauer
Preparation of 18 F-Labeled Tracers Targeting Fibroblast Activation Protein via Sulfur [ 18 F]Fluoride Exchange Reaction. Pharmaceutics 15 (12) (2023)
Torsten Kniess, Jörg Zessin, Peter Mäding, Manuela Kuchar, Oliver C Neels, Klaus Kopka
Synthesis of [ 18 F]FMISO, a hypoxia-specific imaging probe for PET, an overview from a radiochemist's perspective. EJNMMI radiopharmacy and chemistry 8 (1) (2023)
Santiago Andrés Brühlmann, Martin Walther, Martin Kreller, Falco Reissig, Hans-Jürgen Pietzsch, Torsten Kniess, Klaus Kopka
Cyclotron-Based Production of 67 Cu for Radionuclide Theranostics via the 70 Zn(p,α) 67 Cu Reaction. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Carsten Sven Kramer, Thines Kanagasundaram, Jessica Matthias, Klaus Kopka
Efforts toward PET-Activatable Red-Shifted Silicon Rhodamines and Silicon Pyronine Dyes. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Marlene Schlesinger, Christian Jentschel, Hans-Jürgen Pietzsch, Klaus Kopka, Constantin Mamat
Copper-free click bioconjugation of technetium-99m complexes using strained cyclononyne derivatives. Dalton transactions (Cambridge, England : 2003) (2023)
Torsten Kniess, Jörg Zessin, Peter Mäding, Manuela Kuchar, Oliver C Neels, Klaus Kopka
Synthesis of [ 18 F]FMISO, a hypoxia-specific imaging probe for PET, an overview from a radiochemist's perspective. EJNMMI radiopharmacy and chemistry 8 (1) (2023)
Marlene Schlesinger, Christian Jentschel, Hans-Jürgen Pietzsch, Klaus Kopka, Constantin Mamat
Copper-free click bioconjugation of technetium-99m complexes using strained cyclononyne derivatives. Dalton transactions (Cambridge, England : 2003) 52 (10) (2023)
Austin Craig, Jürgen Kogler, Markus Laube, Martin Ullrich, Cornelius K Donat, Robert Wodtke, Klaus Kopka, Sven Stadlbauer
Preparation of 18 F-Labeled Tracers Targeting Fibroblast Activation Protein via Sulfur [ 18 F]Fluoride Exchange Reaction. Pharmaceutics 15 (12) (2023)
Torsten Kniess, Jörg Zessin, Peter Mäding, Manuela Kuchar, Oliver C Neels, Klaus Kopka
Synthesis of [ 18 F]FMISO, a hypoxia-specific imaging probe for PET, an overview from a radiochemist's perspective. EJNMMI radiopharmacy and chemistry 8 (1) (2023)
Valérie Weber, Lucie Arnaud, Sladjana Dukic-Stefanovic, Barbara Wenzel, Valérie Roux, Jean-Michel Chezal, Thu Hang Lai, Rodrigo Teodoro, Klaus Kopka, Elisabeth Miot-Noirault, Winnie Deuther-Conrad, Aurélie Maisonial-Besset
Novel Radioiodinated and Radiofluorinated Analogues of FT-2102 for SPECT or PET Imaging of mIDH1 Mutant Tumours. Molecules (Basel, Switzerland) 27 (12) (2022)
Fabian Krutzek, Klaus Kopka, Sven Stadlbauer
Development of Radiotracers for Imaging of the PD-1/PD-L1 Axis. Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)
Barbara Wenzel, Stefan R Fritzsche, Magali Toussaint, Detlef Briel, Klaus Kopka, Peter Brust, Matthias Scheunemann, Winnie Deuther-Conrad
Radiosynthesis and Preclinical Evaluation of an 18 F-Labeled Triazolopyridopyrazine-Based Inhibitor for Neuroimaging of the Phosphodiesterase 2A (PDE2A). Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Thu Hang Lai, Barbara Wenzel, Rareş-Petru Moldovan, Peter Brust, Klaus Kopka, Rodrigo Teodoro
Automated radiosynthesis of the adenosine A 2A receptor-targeting radiotracer [ 18 F]FLUDA. Journal of labelled compounds & radiopharmaceuticals 65 (6) (2022)
Oliver Clauß, Linda Schäker-Hübner, Barbara Wenzel, Magali Toussaint, Winnie Deuther-Conrad, Daniel Gündel, Rodrigo Teodoro, Sladjana Dukić-Stefanović, Friedrich-Alexander Ludwig, Klaus Kopka, Peter Brust, Finn K Hansen, Matthias Scheunemann
Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [ 18 F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Manja Kubeil, Irma Ivette Santana Martínez, Michael Philipp Bachmann, Klaus Kopka, Kellie L Tuck, Holger Stephan
Dual-Labelling Strategies for Nuclear and Fluorescence Molecular Imaging: Current Status and Future Perspectives. Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)
Daniel Gündel, Magali Toussaint, Thu Hang Lai, Winnie Deuther-Conrad, Paul Cumming, Susann Schröder, Rodrigo Teodoro, Rareş-Petru Moldovan, Francisco Pan-Montojo, Bernhard Sattler, Klaus Kopka, Osama Sabri, Peter Brust
Quantitation of the A 2A Adenosine Receptor Density in the Striatum of Mice and Pigs with [ 18 F]FLUDA by Positron Emission Tomography. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Ann-Christin Eder, Jessica Matthias, Martin Schäfer, Jana Schmidt, Nils Steinacker, Ulrike Bauder-Wüst, Lisa-Charlotte Domogalla, Mareike Roscher, Uwe Haberkorn, Matthias Eder, Klaus Kopka
A New Class of PSMA-617-Based Hybrid Molecules for Preoperative Imaging and Intraoperative Fluorescence Navigation of Prostate Cancer. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Daniel Gündel, Thu Hang Lai, Sladjana Dukic-Stefanovic, Rodrigo Teodoro, Winnie Deuther-Conrad, Magali Toussaint, Klaus Kopka, Rareş-Petru Moldovan, Peter Boknik, Britt Hofmann, Ulrich Gergs, Joachim Neumann, Peter Brust
Non-Invasive Assessment of Locally Overexpressed Human Adenosine 2A Receptors in the Heart of Transgenic Mice. International journal of molecular sciences 23 (3) (2022)
Santiago Andrés Brühlmann, Martin Kreller, Hans-Jürgen Pietzsch, Klaus Kopka, Constantin Mamat, Martin Walther, Falco Reissig
Efficient Production of the PET Radionuclide 133 La for Theranostic Purposes in Targeted Alpha Therapy Using the 134 Ba(p,2n) 133 La Reaction. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Jun Toyohara, Mohammed Al-Qahtani, Ya-Yao Huang, Emiliano Cazzola, Sergio Todde, Shozo Furumoto, Renata Mikolajczak, Clemens Decristoforo, Nic Gillings, Min Yang, Raymond Reilly, Adriano Duatti, Antonia Denkova, Ralf Schirrmacher, Giuseppe Carlucci, Yann Seimbille, Zhaofei Liu, Beverley Ellis, Bart T Cornelissen, Klaus Kopka, Emerson Bernardes
Highlight selection of radiochemistry and radiopharmacy developments by editorial board. EJNMMI radiopharmacy and chemistry 7 (1) (2022)
Falco Reissig, David Bauer, Kristof Zarschler, Zbynek Novy, Katerina Bendova, Marie-Charlotte Ludik, Klaus Kopka, Hans-Jürgen Pietzsch, Milos Petrik, Constantin Mamat
Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA-A Proof of Concept Study. Cancers 13 (8) (2021)
Silvio Aime, Mohammed Al-Qahtani, Martin Behe, Guy Bormans, Giuseppe Carlucci, Jean N DaSilva, Clemens Decristoforo, Adriano Duatti, Philip H Elsinga, Klaus Kopka, Xiang-Guo Li, Zhibo Liu, Robert H Mach, Oskar Middel, Jan Passchier, Marianne Patt, Ivan Penuelas, Ana Rey, Peter J H Scott, Sergio Todde, Jun Toyohara, Danielle Vugts, Zhi Yang
Highlight selection of radiochemistry and radiopharmacy developments by editorial board. EJNMMI radiopharmacy and chemistry 6 (1) (2021)
Karel D Klika, Chiara Da Pieve, Klaus Kopka, Graham Smith, Ata Makarem
Synthesis and application of a thiol-reactive HBED-type chelator for development of easy-to-produce Ga-radiopharmaceutical kits and imaging probes. Organic & biomolecular chemistry 19 (8) (2021)
Oliver C Neels, Klaus Kopka, Christos Liolios, Ali Afshar-Oromieh
Radiolabeled PSMA Inhibitors. Cancers 13 (24) (2021)
Jessica Matthias, Johann Engelhardt, Martin Schäfer, Ulrike Bauder-Wüst, Philipp T Meyer, Uwe Haberkorn, Matthias Eder, Klaus Kopka, Stefan W Hell
Cytoplasmic Localization of Prostate-Specific Membrane Antigen Inhibitors May Confer Advantages for Targeted Cancer Therapies. Cancer research 81 (8) (2021)
Thines Kanagasundaram, Carsten Sven Kramer, Eszter Boros, Klaus Kopka
Rhenium and technetium-complexed silicon rhodamines as near-infrared imaging probes for bimodal SPECT- and optical imaging. Dalton transactions (Cambridge, England : 2003) 49 (22) (2020)
Falco Reissig, David Bauer, Martin Ullrich, Martin Kreller, Jens Pietzsch, Constantin Mamat, Klaus Kopka, Hans-Jürgen Pietzsch, Martin Walther
Recent Insights in Barium-131 as a Diagnostic Match for Radium-223: Cyclotron Production, Separation, Radiolabeling, and Imaging. Pharmaceuticals (Basel, Switzerland) 13 (10) (2020)
Markus Laube, Cemena Gassner, Christin Neuber, Robert Wodtke, Martin Ullrich, Cathleen Haase-Kohn, Reik Löser, Martin Köckerling, Klaus Kopka, Torsten Kniess, Evamarie Hey-Hawkins, Jens Pietzsch
Deuteration versus ethylation - strategies to improve the metabolic fate of an 18 F-labeled celecoxib derivative. RSC advances 10 (63) (2020)
Stefan Wagner, Fernando de Moura Gatti, Daniel Gedder Silva, Natalia V Ortiz Zacarias, Annelien J M Zweemer, Sven Hermann, Monica De Maria, Michael Koch, Christina Weiss, Dirk Schepmann, Laura H Heitman, Nuska Tschammer, Klaus Kopka, Anna Junker
Development of the First Potential Nonpeptidic Positron Emission Tomography Tracer for the Imaging of CCR2 Receptors. ChemMedChem 16 (4) (2020)
Ute Hennrich, Klaus Kopka
Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy. Pharmaceuticals (Basel, Switzerland) 12 (3) (2019)
Jessica Matthias, Thines Kanagasundaram, Klaus Kopka, Carsten Sven Kramer
Synthesis of a dihalogenated pyridinyl silicon rhodamine for mitochondrial imaging by a halogen dance rearrangement. Beilstein journal of organic chemistry 15 (2019)
Thines Kanagasundaram, Antje Timmermann, Carsten Sven Kramer, Klaus Kopka
A new approach to silicon rhodamines by Suzuki-Miyaura coupling - scope and limitations. Beilstein journal of organic chemistry 15 (2019)

Klaus Kopka.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Klaus Kopka